183 related articles for article (PubMed ID: 27462087)
1. The NK1R-/- mouse phenotype suggests that small body size, with a sex- and diet-dependent excess in body mass and fat, are physical biomarkers for a human endophenotype with vulnerability to attention deficit hyperactivity disorder.
Pillidge K; Heal DJ; Stanford SC
J Psychopharmacol; 2016 Sep; 30(9):848-55. PubMed ID: 27462087
[TBL] [Abstract][Full Text] [Related]
2. A lack of functional NK1 receptors explains most, but not all, abnormal behaviours of NK1R-/- mice(1).
Porter AJ; Pillidge K; Tsai YC; Dudley JA; Hunt SP; Peirson SN; Brown LA; Stanford SC
Genes Brain Behav; 2015 Feb; 14(2):189-99. PubMed ID: 25558794
[TBL] [Abstract][Full Text] [Related]
3. The angiotensin converting enzyme inhibitor, captopril, prevents the hyperactivity and impulsivity of neurokinin-1 receptor gene 'knockout' mice: sex differences and implications for the treatment of attention deficit hyperactivity disorder.
Porter AJ; Pillidge K; Grabowska EM; Stanford SC
Eur Neuropsychopharmacol; 2015 Apr; 25(4):512-21. PubMed ID: 25703442
[TBL] [Abstract][Full Text] [Related]
4. Differences in the performance of NK1R-/- ('knockout') and wildtype mice in the 5‑Choice Continuous Performance Test.
Porter AJ; Pillidge K; Stanford SC; Young JW
Behav Brain Res; 2016 Feb; 298(Pt B):268-77. PubMed ID: 26522842
[TBL] [Abstract][Full Text] [Related]
5. Perseveration by NK1R-/- ('knockout') mice is blunted by doses of methylphenidate that affect neither other aspects of their cognitive performance nor the behaviour of wild-type mice in the 5-Choice Continuous Performance Test.
Pillidge K; Porter AJ; Young JW; Stanford SC
J Psychopharmacol; 2016 Sep; 30(9):837-47. PubMed ID: 27097734
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of L-type Ca(v) channels with nifedipine differentially affects performance of wildtype and NK1R-/- mice in the 5-Choice Serial Reaction-Time Task.
Dudley JA; Weir RK; Yan TC; Grabowska EM; Grimmé AJ; Amini S; Stephens DN; Hunt SP; Stanford SC
Neuropharmacology; 2013 Jan; 64():329-36. PubMed ID: 22884624
[TBL] [Abstract][Full Text] [Related]
7. NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD.
Yan TC; McQuillin A; Thapar A; Asherson P; Hunt SP; Stanford SC; Gurling H
J Psychopharmacol; 2010 Jan; 24(1):27-38. PubMed ID: 19204064
[TBL] [Abstract][Full Text] [Related]
8. Atomoxetine reduces hyperactive/impulsive behaviours in neurokinin-1 receptor 'knockout' mice.
Pillidge K; Porter AJ; Vasili T; Heal DJ; Stanford SC
Pharmacol Biochem Behav; 2014 Dec; 127():56-61. PubMed ID: 25450119
[TBL] [Abstract][Full Text] [Related]
9. Behavioural and neurochemical abnormalities in mice lacking functional tachykinin-1 (NK1) receptors: a model of attention deficit hyperactivity disorder.
Yan TC; Hunt SP; Stanford SC
Neuropharmacology; 2009 Dec; 57(7-8):627-35. PubMed ID: 19748515
[TBL] [Abstract][Full Text] [Related]
10. The influence of test experience and NK1 receptor antagonists on the performance of NK1R-/- and wild type mice in the 5-Choice Serial Reaction-Time Task.
Weir RK; Dudley JA; Yan TC; Grabowska EM; Peña-Oliver Y; Ripley TL; Stephens DN; Stanford SC; Hunt SP
J Psychopharmacol; 2014 Mar; 28(3):270-81. PubMed ID: 23845920
[TBL] [Abstract][Full Text] [Related]
11. Performance deficits of NK1 receptor knockout mice in the 5-choice serial reaction-time task: effects of d-amphetamine, stress and time of day.
Yan TC; Dudley JA; Weir RK; Grabowska EM; Peña-Oliver Y; Ripley TL; Hunt SP; Stephens DN; Stanford SC
PLoS One; 2011 Mar; 6(3):e17586. PubMed ID: 21408181
[TBL] [Abstract][Full Text] [Related]
12. Raised arterial blood pressure in neurokinin-1 receptor-deficient mice (NK1R(-/-) ): evidence for a neural rather than a vascular mechanism.
Moyes AJ; Stanford SC; Hosford PS; Hobbs AJ; Ramage AG
Exp Physiol; 2016 May; 101(5):588-98. PubMed ID: 26876733
[TBL] [Abstract][Full Text] [Related]
13. The behavioural response of mice lacking NK₁ receptors to guanfacine resembles its clinical profile in treatment of ADHD.
Pillidge K; Porter AJ; Dudley JA; Tsai YC; Heal DJ; Stanford SC
Br J Pharmacol; 2014 Oct; 171(20):4785-96. PubMed ID: 25074741
[TBL] [Abstract][Full Text] [Related]
14. Genetic association of the tachykinin receptor 1 TACR1 gene in bipolar disorder, attention deficit hyperactivity disorder, and the alcohol dependence syndrome.
Sharp SI; McQuillin A; Marks M; Hunt SP; Stanford SC; Lydall GJ; Morgan MY; Asherson P; Curtis D; Gurling HM
Am J Med Genet B Neuropsychiatr Genet; 2014 Jun; 165B(4):373-80. PubMed ID: 24817687
[TBL] [Abstract][Full Text] [Related]
15. Animal Models of ADHD?
Stanford SC
Curr Top Behav Neurosci; 2022; 57():363-393. PubMed ID: 35604570
[TBL] [Abstract][Full Text] [Related]
16. Choice-impulsivity in children and adolescents with attention-deficit/hyperactivity disorder (ADHD): A meta-analytic review.
Patros CH; Alderson RM; Kasper LJ; Tarle SJ; Lea SE; Hudec KL
Clin Psychol Rev; 2016 Feb; 43():162-74. PubMed ID: 26602954
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the validity of the use of the spontaneously hypertensive rat as a model of attention deficit hyperactivity disorder in males and females.
Bayless DW; Perez MC; Daniel JM
Behav Brain Res; 2015 Jun; 286():85-92. PubMed ID: 25724583
[TBL] [Abstract][Full Text] [Related]
18. Rodent models of attention-deficit/hyperactivity disorder.
Sagvolden T; Russell VA; Aase H; Johansen EB; Farshbaf M
Biol Psychiatry; 2005 Jun; 57(11):1239-47. PubMed ID: 15949994
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of impulsivity and aggression in mice deficient for the ADHD risk gene Adgrl3: Evidence for dopamine transporter dysregulation.
Mortimer N; Ganster T; O'Leary A; Popp S; Freudenberg F; Reif A; Soler Artigas M; Ribasés M; Ramos-Quiroga JA; Lesch KP; Rivero O
Neuropharmacology; 2019 Sep; 156():107557. PubMed ID: 30849401
[TBL] [Abstract][Full Text] [Related]
20. Further evidence for the association of the NPSR1 gene A/T polymorphism (Asn107Ile) with impulsivity and hyperactivity.
Laas K; Eensoo D; Paaver M; Lesch KP; Reif A; Harro J
J Psychopharmacol; 2015 Aug; 29(8):878-83. PubMed ID: 25744621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
